Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1979 1
1981 2
1982 1
1983 3
1985 3
1986 2
1987 4
1988 6
1989 4
1991 3
1992 3
1994 3
1995 3
1996 2
1997 3
1998 3
1999 2
2000 2
2001 1
2002 3
2003 1
2004 1
2005 2
2006 1
2007 3
2008 1
2009 4
2010 3
2011 4
2012 1
2013 1
2014 6
2015 2
2020 3
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab-induced hypersensitivity pneumonitis.
Tonelli AR, Lottenberg R, Allan RW, Sriram PS. Tonelli AR, et al. Among authors: lottenberg r. Respiration. 2009;78(2):225-9. doi: 10.1159/000163069. Epub 2008 Oct 9. Respiration. 2009. PMID: 18843175 Free PMC article.
Evidence gaps in the management of sickle cell disease: A summary of needed research.
Savage WJ, Buchanan GR, Yawn BP, Afenyi-Annan AN, Ballas SK, Goldsmith JC, Hassell KL, James AH, John-Sowah J, Jordan L, Lottenberg R, Murad MH, Ortiz E, Tanabe PJ, Ware RE, Lanzkron SM. Savage WJ, et al. Among authors: lottenberg r. Am J Hematol. 2015 Apr;90(4):273-5. doi: 10.1002/ajh.23945. Epub 2015 Feb 17. Am J Hematol. 2015. PMID: 25639238 Free article. No abstract available.
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Hankins JS, Brambilla D, Potter MB, Kutlar A, Gibson R, King AA, Baumann AA, Melvin C, Gordeuk VR, Hsu LL, Nwosu C, Porter JS, Alberts NM, Badawy SM, Simon J, Glassberg JA, Lottenberg R, DiMartino L, Jacobs S, Fernandez ME, Bosworth HB, Klesges LM, Shah N. Hankins JS, et al. Among authors: lottenberg r. Blood Adv. 2023 Dec 12;7(23):7190-7201. doi: 10.1182/bloodadvances.2023010670. Blood Adv. 2023. PMID: 37738155 Free PMC article. Clinical Trial.
Bacterial adaptation and infection.
Boyle MD, Lottenberg R. Boyle MD, et al. Among authors: lottenberg r. Inflamm Allergy Drug Targets. 2010 Sep;9(4):238-48. doi: 10.2174/187152810793358769. Inflamm Allergy Drug Targets. 2010. PMID: 20887271 Review.
Pneumococcal vaccines for sickle cell disease.
Davies EG, Riddington C, Lottenberg R, Dower N. Davies EG, et al. Among authors: lottenberg r. Cochrane Database Syst Rev. 2004;(1):CD003885. doi: 10.1002/14651858.CD003885.pub2. Cochrane Database Syst Rev. 2004. PMID: 14974042 Review.
Update on the use of hydroxyurea therapy in sickle cell disease.
Wong TE, Brandow AM, Lim W, Lottenberg R. Wong TE, et al. Among authors: lottenberg r. Blood. 2014 Dec 18;124(26):3850-7; quiz 4004. doi: 10.1182/blood-2014-08-435768. Epub 2014 Oct 6. Blood. 2014. PMID: 25287707 Free PMC article. Review. No abstract available.
93 results